Phase III clinical trial - Appareil pulmonaire

BR.31 (IFCT1401)
Appareil pulmonaire
Ouvert depuis le: 10.14.2019
Site: Paris
Public cible
Adulte
A Phase III Prospective Double Blind Placebo Controlled Randomized Study of Adjuvant MEDI4736 In Completely Resected Non-Small Cell Lung Cancer
Description de l'essai

The purpose of this study is to find out whether it is better to receive a new drug, MEDI4736, or better to receive no further treatment after surgery (and possibly chemotherapy) for lung cancer.